Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS withdrawal · 2017-03-30

Clinical Trial Update: Piracetam for Treatment of Cocaine Addiction, Phase II - 4 [Phase 1]

View source ↗

Summary

Withdrawal notice for a piracetam trial targeting cocaine use disorder, indicating the study has been withdrawn. The trial was sponsored by the University of Pe…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Piracetam (piracetam)

Snippet

Sponsor: University of Pennsylvania | Conditions: Cocaine-Related Disorders | Phase 1 | Status: WITHDRAWN